Sanofi-Aventis Buys Merial Stake From Merck
<p>September 21, 2009, 2009 (FinancialWire) — French drugmaker Sanofi-aventis (NYSE: SNY) has acquired Merck & Co., Inc.’s (NYSE: MRK) 50 percent interest in Merial Ltd. for $4 billion in cash.<span id="more-10513…